Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Focused ultrasound spleen stimulation for septic shock in adults

Official title: Effects of Focused Ultrasound Spleen Neuromodulation on Inflammatory Cytokine Levels in Patients With Septic Shock: A Randomized Controlled Pilot Trial

Run by First Affiliated Hospital of Wannan Medical College · NCT06990295 · Data updated 2026-11-12

This trial tests whether non-invasive ultrasound aimed at the spleen can help reduce inflammation in adults with septic shock.

More Critical Care trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorFirst Affiliated Hospital of Wannan Medical College
Academic / other
Locations1 site (Wuhu, Anhui)
StatusRecruiting
StartedJuly 25, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 19, 2026
Trial IDNCT06990295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with septic shock admitted to the ICU within 24 hours and expected to need intensive care for at least 72 hours.

Probably not a fit

Patients without a response to the intervention or with contraindications to ultrasound splenic treatment may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized pilot study, adults with septic shock receive either standard care or standard care plus twice-daily, non-invasive focused ultrasound to the spleen for five days. The goal is to see if spleen neuromodulation lowers inflammatory cytokines and influences organ function. Researchers will measure cytokine levels (TNF-α, IL-1β, IL-6, IL-10), lymphocyte subpopulations, SOFA scores, ICU stay, and 28-day mortality, while monitoring safety. The study uses a portable device to deliver targeted energy to the splenic region in the intervention arm. Outcomes will help determine if this approach is a safe and potentially effective immunomodulatory therapy for septic shock.

Why it matters

Potential benefit: If successful, patients could experience reduced inflammation and better organ function, potentially improving recovery in septic shock.

How similar studies have gone: Previous approaches targeting immune modulation in septic shock have shown mixed results; this is a novel, early-stage pilot evaluating spleen-focused ultrasound.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years, regardless of sex
* Diagnosed with septic shock according to Sepsis-3 criteria: Sequential Organ Failure Assessment (SOFA) score ≥ 2 and requiring vasopressor support to maintain a mean arterial pressure (MAP) ≥ 65 mmHg.
* Admitted to the ICU within 24 hours of septic shock diagnosis
* Expected to require intensive care for at least 72 hours
* Informed consent obtained from the patient or legal representative

Exclusion Criteria:

* Known pregnancy or breastfeeding
* Participation in another interventional clinical trial within 30 days
* Known immunodeficiency or ongoing immunosuppressive therapy
* Malignancy with life expectancy \< 6 months
* Contraindications to focused ultrasound (e.g., splenic trauma, splenectomy, local skin infection)
* Do-not-resuscitate (DNR) order or expected death within 24 hours
* Any other condition deemed unsuitable for participation by the investigators

Where it's running

  • The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
    Wuhu, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.